Mahalingam, Devalingam http://orcid.org/0000-0002-2979-9894
Harb, Wael
Patnaik, Amita
Bullock, Andrea http://orcid.org/0000-0001-7143-0225
Watnick, Randolph S.
Vincent, Melanie Y.
Chen, Jian Jenny http://orcid.org/0009-0003-3598-8047
Wang, Suming
Pestana, Harold
Chao, Judy
Mahoney, James
Cieslewicz, Michael
Watnick, Jing http://orcid.org/0000-0003-0475-3299
Funding for this research was provided by:
private venture funding
Article History
Received: 31 March 2023
Accepted: 4 January 2024
First Online: 13 January 2024
Competing interests
: Vigeo Therapeutics designed and sponsored the clinical study in this article. R.S.W. is a co-founder of, and consultant for, Vigeo Therapeutics, which has licensed technology from Boston Children’s Hospital. M.Y.V., J.J.C., S.W., H.P., J.C., J.M., M.C., and J.W. are employees of Vigeo Therapeutics. D.M., W.H., A.P., and A.B. declare no competing interests.